| Senior Lead, TA Medical（General Medicines） |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Gegužė 27, 2024 |
| Clinical Biospecimen Senior Scientist |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Rug 03, 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Bir 26, 2024 |
| Japan Program Head (Neuroscience & GTx) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Japan Program Head (Immunology) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Manager, TRD Project management |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Associate Clinical Project Manager |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| Associate Director, Global Function Finance DDIT |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Operations |
CTS |
Technology Transformation |
Rug 04, 2024 |
| TA Strategy Lead - Hematology |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Bir 26, 2024 |
| Agile Project Management Lead |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Technology Transformation |
Lie 01, 2024 |
| Associate Director Pipeline Management |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lie 10, 2024 |
| Japan Program Manager |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lie 10, 2024 |
| Sr. TA Strategy Lead (Renal Therapy Area) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Rugp 07, 2024 |
| P&O Business Partner Development & Biomedical Research Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
People & Organization |
Innovative Medicines |
Human Resources |
Rug 03, 2024 |
| Manager, Reg&Dev Policy Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Rug 12, 2024 |
| Lead, Medical Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 02, 2024 |
| TME Profiling |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
Lie 07, 2024 |
| Clinical Sciences Trial Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
Lie 10, 2024 |
| Lead, RWE and Evidence Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 10, 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lie 18, 2024 |
| Associate/Manager, MSL（Oncology） |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 22, 2024 |
| Solution Design |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Rug 03, 2024 |
| Associate/Manager, MSL (Cardiovascular) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rugp 20, 2024 |
| Medical Field Trainer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rugp 29, 2024 |
| Study Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Rug 05, 2024 |
| Group Manager, MSL |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rug 05, 2024 |
| Japan Program Clinical Head (IMM) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Innovative Medicines |
Research & Development |
Rug 10, 2024 |
| Lead/Associate, CX Content Creation |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Rug 17, 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Spa 02, 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Spa 04, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Spa 07, 2024 |
| Lead, Integrated Insights & Planning_市場調査 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Spa 07, 2024 |
| Manager, Financial Control & Compliance (FC&C) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Spa 06, 2024 |
| Associate, TA Medical (General Medicines) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Spa 07, 2024 |
| Head Regulatory Writing |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 07, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Investigation Expert |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Spa 18, 2024 |
| Associate, QA Officer Operations |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Rug 03, 2024 |
| Project Engineer (Design Phase)_RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Rug 03, 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis |
Sasayama |
Japan |
Finance |
Innovative Medicines |
Audit & Finance |
Rug 17, 2024 |
| Technical System Lead (Qualification) |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Lie 31, 2024 |